Aging and malignant hemopathies.
作者信息
Bron Dominique, Ades Lionel, Fulop Tamas, Goede Valentin
机构信息
Department Clinical and Experimental Hematology, Institut Jules Bordet (ULB), Brussels, Belgium
Hopital Saint Louis, Paris, France.
出版信息
Haematologica. 2015 May;100(5):571-4. doi: 10.3324/haematol.2014.117721.
Abstract
摘要
相似文献
1
Aging and malignant hemopathies.衰老与恶性血液病
Haematologica. 2015 May;100(5):571-4. doi: 10.3324/haematol.2014.117721.
2
Innovative approach to older patients with malignant hemopathies.针对老年恶性血液病患者的创新方法。
Haematologica. 2016 Aug;101(8):893-5. doi: 10.3324/haematol.2016.142810.
3
Therapy for Hematologic Cancers in Older Patients, Quality of Life, and Health Economics: Difficult Decisions.老年血液系统癌症的治疗、生活质量与卫生经济学：艰难抉择
JAMA Oncol. 2015 Aug;1(5):571-2. doi: 10.1001/jamaoncol.2015.1084.
4
The best of times in hematologic malignancies.血液系统恶性肿瘤的黄金时代。
Curr Opin Hematol. 2015 Mar;22(2):75-6. doi: 10.1097/MOH.0000000000000126.
5
Should we transplant indolent lymphoma?我们应该移植惰性淋巴瘤吗？
J Clin Oncol. 2005 Sep 1;23(25):6263-4; author reply 6264-6. doi: 10.1200/JCO.2005.01.5131.
6
[Geriatric assessment for elderly patients with haematological malignancies].老年血液系统恶性肿瘤患者的老年综合评估
Rev Med Interne. 2012 Dec;33 Suppl 2:A24-7. doi: 10.1016/j.revmed.2012.09.016. Epub 2012 Oct 23.
7
[Benign and malignant hemopathies in elderly patients].
Vutr Boles. 1989;28(6):64-8.
8
New Horizons for Immune Gene Therapy.免疫基因治疗的新视野
Hum Gene Ther. 2019 Apr;30(4):379-380. doi: 10.1089/hum.2019.29085.aba.
9
[Management problems of malignant hemopathies among children in Senegal].[塞内加尔儿童恶性血液病的管理问题]
Dakar Med. 2002;47(1):12-7.
10
Update on the treatment of HIV-associated hematologic malignancies.HIV 相关血液系统恶性肿瘤的治疗进展
Hematology Am Soc Hematol Educ Program. 2013;2013:382-8. doi: 10.1182/asheducation-2013.1.382.
引用本文的文献
1
Host-related factors and cancer: Malnutrition and non-Hodgkin lymphoma.宿主相关因素与癌症：营养不良与非霍奇金淋巴瘤。
Hematol Oncol. 2022 Aug;40(3):320-331. doi: 10.1002/hon.3002. Epub 2022 Apr 18.
2
Aging of Bone Marrow Mesenchymal Stromal Cells: Hematopoiesis Disturbances and Potential Role in the Development of Hematologic Cancers.骨髓间充质基质细胞衰老：造血紊乱及其在血液系统恶性肿瘤发生中的潜在作用
Cancers (Basel). 2020 Dec 29;13(1):68. doi: 10.3390/cancers13010068.
3
Structured assessment of frailty in multiple myeloma as a paradigm of individualized treatment algorithms in cancer patients at advanced age.多发性骨髓瘤患者衰弱的结构化评估作为老年癌症患者个体化治疗算法的范例
Haematologica. 2020 May;105(5):1183-1188. doi: 10.3324/haematol.2019.242958. Epub 2020 Apr 2.
4
Age-related changes in the BACH2 and PRDM1 genes in lymphocytes from healthy donors and chronic lymphocytic leukemia patients.健康供者和慢性淋巴细胞白血病患者淋巴细胞中 BACH2 和 PRDM1 基因的年龄相关变化。
BMC Cancer. 2019 Jan 17;19(1):81. doi: 10.1186/s12885-019-5276-2.
5
Innovative approach to older patients with malignant hemopathies.针对老年恶性血液病患者的创新方法。
Haematologica. 2016 Aug;101(8):893-5. doi: 10.3324/haematol.2016.142810.
本文引用的文献
1
Interactions between comorbidity and treatment of chronic lymphocytic leukemia: results of German Chronic Lymphocytic Leukemia Study Group trials.慢性淋巴细胞白血病合并症与治疗之间的相互作用：德国慢性淋巴细胞白血病研究组试验结果
Haematologica. 2014 Jun;99(6):1095-100. doi: 10.3324/haematol.2013.096792. Epub 2014 Feb 28.
2
Idelalisib and rituximab in relapsed chronic lymphocytic leukemia.依鲁替尼联合利妥昔单抗治疗复发慢性淋巴细胞白血病。
N Engl J Med. 2014 Mar 13;370(11):997-1007. doi: 10.1056/NEJMoa1315226. Epub 2014 Jan 22.
3
Obinutuzumab plus chlorambucil in patients with CLL and coexisting conditions.奥滨尤妥珠单抗联合苯丁酸氮芥治疗伴有合并症的 CLL 患者。
N Engl J Med. 2014 Mar 20;370(12):1101-10. doi: 10.1056/NEJMoa1313984. Epub 2014 Jan 8.
4
Ibrutinib as initial therapy for elderly patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: an open-label, multicentre, phase 1b/2 trial.伊布替尼作为初治老年慢性淋巴细胞白血病或小淋巴细胞淋巴瘤患者的治疗方案：一项开放标签、多中心、1b/2 期临床试验。
Lancet Oncol. 2014 Jan;15(1):48-58. doi: 10.1016/S1470-2045(13)70513-8. Epub 2013 Dec 10.
5
Phosphoinositide 3-kinase inhibition restores neutrophil accuracy in the elderly: toward targeted treatments for immunosenescence.磷酸肌醇 3-激酶抑制作用恢复老年人中性粒细胞的准确性：免疫衰老的靶向治疗。
Blood. 2014 Jan 9;123(2):239-48. doi: 10.1182/blood-2013-08-519520. Epub 2013 Nov 4.
6
Age-dependent dysregulation of innate immunity.年龄相关的固有免疫失调。
Nat Rev Immunol. 2013 Dec;13(12):875-87. doi: 10.1038/nri3547. Epub 2013 Oct 25.
7
From "truly naïve" to "exhausted senescent" T cells: when markers predict functionality.从“真正幼稚”到“疲惫衰老”的 T 细胞：当标志物预示着功能。
Cytometry A. 2014 Jan;85(1):25-35. doi: 10.1002/cyto.a.22351. Epub 2013 Sep 30.
8
Intensive induction is effective in selected octogenarian acute myeloid leukemia patients: prognostic significance of karyotype and selected molecular markers used in the European LeukemiaNet classification.在选定的 80 岁以上急性髓系白血病患者中，强化诱导治疗是有效的：欧洲白血病网络分类中使用的核型和选定分子标志物的预后意义。
Haematologica. 2014 Feb;99(2):308-13. doi: 10.3324/haematol.2013.092072. Epub 2013 Oct 4.
9
Human T cell aging and the impact of persistent viral infections.人类T细胞衰老及持续性病毒感染的影响
Front Immunol. 2013 Sep 13;4:271. doi: 10.3389/fimmu.2013.00271.
10
The hallmarks of aging.衰老的特征。
Cell. 2013 Jun 6;153(6):1194-217. doi: 10.1016/j.cell.2013.05.039.
Zotero 插件